hg_132327.1

Basic information about the TSS

---

TSS ID: hg_132327.1 Species: human Chr: chr12		Start: 82358744 End: 82358785 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000548126.1 uc021rbm.2 Distance: -1 GeneID: 29080 HGNC/MGI_ID: HGNC:25005 UniProt_ID:

Gene_name: coiled-coil domain containing 59 Gene_symbol: CCDC59 Gene_synonyms: BR22 HSPC128 TAP26 Gene_source: HGNC:25005

TATA-Box annotation

---

Distance to TSS:	40
Nearest PromoterID:	NR_033192
Entrez ID:	29080
Nearest Unigene:	Hs.582627
Nearest Refseq:	NM_014167
Nearest Ensembl:	ENSG00000133773
Gene Name:	coiled-coil domain containing 59
Gene Alias:	BR22
Gene Description:	coiled-coil domain containing 59
Gene Type:	protein-coding
CpG%:	0.065
GC%:	0.641791
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CCDC59 p2@CCDC59 p3@CCDC59
Sample		p1@CCDC59	p2@CCDC59	p3@CCDC59
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	91.95	19.87	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	78.70	17.20	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	94.33	20.45	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	63.83	23.70	1.87
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	81.89	17.55	2.02
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	94.39	19.96	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	122.01	25.71	3.49
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	93.98	17.44	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	78.01	18.38	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	74.77	41.15	2.90
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	71.55	35.57	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	86.60	37.81	3.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.99	4.35	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.04	7.97	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	20.20	6.15	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.86	7.80	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.66	5.68	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	20.67	7.59	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	18.13	7.46	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.61	7.22	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	17.64	7.62	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	24.17	8.29	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	17.84	7.88	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	19.17	6.55	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	22.45	4.90	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	27.22	6.33	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	24.73	3.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	23.81	5.19	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	19.87	4.85	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.79	5.25	0.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	23.66	4.61	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	16.61	3.71	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.48	3.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	37.44	7.75	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	21.50	4.11	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	20.89	2.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	22.28	2.66	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.34	3.83	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	24.58	4.05	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	19.69	4.32	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	22.82	3.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	26.64	4.54	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	19.82	3.59	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	17.31	3.67	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	23.49	4.42	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	18.84	5.58	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	17.27	4.80	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	18.78	4.17	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.88	2.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.60	2.02	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.40	4.30	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.90	2.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	517.71	13.99	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	12.07	3.19	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	12.59	1.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	98.99	20.97	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	31.23	5.97	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.08	2.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.35	1.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	30.49	4.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	2.82	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	8.41	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	43.79	5.57	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	20.39	4.08	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	9.10	2.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	9.58	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	452.59	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	434.36	23.69	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	17.06	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.41	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	1.88	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.88	3.64	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	15.16	2.78	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	10.40	2.45	0.31
Adipocyte - breast, donor1	11376-118A8	34.37	7.29	0.63
Adipocyte - breast, donor2	11327-117E4	20.21	4.33	0.96
Adipocyte - omental, donor1	11473-119C6	37.02	9.16	1.65
Adipocyte - omental, donor2	11474-119C7	14.20	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	16.75	6.03	0.67
Adipocyte - perirenal, donor1	11476-119C9	21.05	1.28	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	1.10	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	14.90	6.32	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	10.43	2.95	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	30.12	3.91	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	28.31	1.54	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	30.94	4.18	1.39
Adipocyte differentiation, day04, donor4	13028-139E4	39.38	5.29	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	28.39	9.65	1.45
Adipocyte differentiation, day08, donor2	13023-139D8	23.88	8.07	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	19.73	2.67	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	24.48	7.79	2.23
Adipocyte differentiation, day12, donor1	13021-139D6	18.30	3.33	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	17.08	4.77	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	17.34	4.91	1.64
Adipocyte differentiation, day12, donor4	13030-139E6	15.22	5.78	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	16.80	1.99	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	5.02	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	12.05	2.88	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	3.35	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	7.19	2.67	0.00
Anulus Pulposus Cell, donor1	11248-116E6	33.30	6.87	0.80
Anulus Pulposus Cell, donor2	11463-119B5	12.74	4.41	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.17	4.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.50	5.21	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	27.82	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	15.25	5.08	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	18.97	8.85	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.86	4.62	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	19.17	5.85	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	16.99	5.83	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.25	4.16	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	17.70	5.65	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	16.69	2.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	7.52	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	21.25	10.05	1.15
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	6.82	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	14.17	4.98	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	17.15	3.75	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	17.95	3.97	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.24	4.54	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	2.93	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	14.76	5.14	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	13.21	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	10.62	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	15.27	3.77	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	13.11	7.28	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	19.35	6.45	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	6.06	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.96	2.85	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.96	4.92	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.58	3.61	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	6.10	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.47	4.50	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	4.28	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	19.89	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	14.15	5.42	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	7.13	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.78	4.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	13.75	5.86	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	5.08	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	18.99	3.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	16.72	4.45	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.63	4.64	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	14.17	4.72	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.26	3.56	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	14.15	4.50	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	13.84	5.41	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	23.33	2.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	18.85	3.22	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	12.75	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	16.02	6.61	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.31	4.54	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.30	3.98	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	20.08	8.13	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.74	5.10	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	12.21	4.58	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	22.71	6.09	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	18.80	4.24	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	10.90	5.09	0.00
Astrocyte - cerebellum, donor1	11500-119F6	20.88	2.70	0.49
Astrocyte - cerebellum, donor2	11580-120F5	9.07	0.68	0.17
Astrocyte - cerebellum, donor3	11661-122F5	6.92	0.63	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	48.10	3.49	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	38.50	3.72	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	35.80	2.09	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	77.53	20.87	3.78
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	76.05	30.57	3.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	76.13	27.88	5.35
Basophils, donor1	12241-129G9	103.83	27.46	1.31
Basophils, donor2	12242-129H1	186.17	63.86	5.41
Basophils, donor3	12243-129H2	84.82	33.37	3.38
Bronchial Epithelial Cell, donor1	11511-119G8	8.41	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	28.87	5.02	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	9.98	0.21	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	21.19	1.15	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	25.73	3.42	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	57.50	25.97	6.18
Burkitt's lymphoma cell line:RAJI	10476-106I8	97.82	14.21	6.29
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	118.64	31.66	4.16
CD133+ stem cells - cord blood derived, pool1	12223-129E9	227.52	82.74	0.00
CD14+ Monocytes, donor1	11224-116B9	139.20	36.63	0.00
CD14+ Monocytes, donor2	11305-117B9	101.71	26.73	1.30
CD14+ Monocytes, donor3	11381-118B4	98.57	23.05	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	26.61	12.45	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.16	17.44	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	20.38	18.41	1.97
CD14+ monocytes - mock treated, donor1	11863-125A9	28.91	12.00	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	30.78	10.86	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	28.90	10.90	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	26.78	7.87	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	39.75	4.42	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	65.70	6.94	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	34.27	3.33	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	49.85	5.52	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	102.50	10.66	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	42.38	7.73	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	77.62	18.48	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	80.98	17.75	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	30.05	10.11	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	41.91	6.59	0.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	76.62	10.83	1.04
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	36.38	7.09	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	66.96	10.41	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	51.07	6.55	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	30.66	7.80	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	32.97	6.63	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	50.08	7.15	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	48.13	4.23	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	68.34	4.23	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	77.65	5.26	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	35.75	4.88	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	55.01	5.95	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	103.68	15.09	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	33.99	5.73	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	88.32	8.58	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	96.51	8.58	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	85.01	58.20	4.14
CD14+CD16+ Monocytes, donor2	11801-124D1	87.32	57.98	3.70
CD14+CD16+ Monocytes, donor3	11912-125G4	85.78	56.54	2.60
CD14+CD16- Monocytes, donor1	11788-124B6	96.55	40.64	4.67
CD14+CD16- Monocytes, donor2	11799-124C8	90.47	45.41	3.84
CD14+CD16- Monocytes, donor3	11910-125G2	117.28	54.40	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	64.56	58.95	4.59
CD14-CD16+ Monocytes, donor2	11800-124C9	70.92	62.14	3.95
CD14-CD16+ Monocytes, donor3	11911-125G3	75.38	64.01	5.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	83.32	54.87	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	74.58	36.61	7.46
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	66.28	55.92	7.25
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	102.88	53.30	5.86
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	92.74	62.18	10.19
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	80.02	47.03	11.23
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	98.04	48.63	3.14
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	125.24	77.78	2.64
CD19+ B Cells, donor1	11544-120B5	170.13	43.56	0.82
CD19+ B Cells, donor2	11624-122B4	146.54	47.15	4.35
CD19+ B Cells, donor3	11705-123B4	157.51	41.90	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	203.24	12.53	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	135.83	8.79	2.40
CD34+ Progenitors, donor1	11545-120B6	129.52	26.11	1.00
CD34+ Progenitors, donor2	11625-122B5	194.39	46.63	2.81
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	76.65	23.30	4.51
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	95.83	30.67	4.51
CD4+ T Cells, donor1	11225-116C1	323.49	119.26	6.43
CD4+ T Cells, donor2	11306-117C1	190.44	53.28	1.22
CD4+ T Cells, donor3	11382-118B5	169.58	46.66	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	73.00	34.97	4.59
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	59.97	30.77	4.94
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	58.64	32.20	3.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	311.95	97.19	9.01
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	302.00	94.81	9.83
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	148.33	65.92	6.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	51.45	28.04	4.05
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	35.76	15.42	3.22
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	37.88	16.44	2.58
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	195.01	64.55	5.83
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	186.22	53.46	5.59
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	183.47	84.48	6.60
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	80.11	40.06	5.06
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	33.04	15.37	2.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.76	15.70	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	236.85	92.73	11.15
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	226.17	97.01	4.82
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	206.22	73.52	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	59.89	29.11	6.12
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	46.14	22.96	3.68
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	48.12	24.80	2.94
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	197.19	66.23	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	182.83	69.75	5.63
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	217.47	101.98	7.41
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	125.70	66.31	11.38
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	94.16	56.31	11.08
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	108.87	68.40	8.37
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	138.74	74.77	16.62
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	136.68	74.35	13.01
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	93.94	77.00	10.78
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	115.67	51.57	8.24
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	159.27	65.09	6.92
CD8+ T Cells, donor1	11226-116C2	196.11	81.19	6.88
CD8+ T Cells, donor2	11307-117C2	119.76	41.30	3.00
CD8+ T Cells, donor3	11383-118B6	174.97	74.23	5.55
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	53.22	8.03	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	52.72	7.43	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	54.44	10.12	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	73.25	17.71	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	54.72	10.08	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	53.89	12.28	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	54.32	5.65	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	49.48	6.32	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	55.81	6.33	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	68.22	9.06	2.42
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	59.26	7.26	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	75.13	9.59	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	45.53	2.63	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	56.02	4.10	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	49.97	5.22	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	50.78	7.20	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	52.08	6.04	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	48.79	8.49	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	73.20	6.65	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	65.20	4.92	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	63.48	3.53	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	72.29	4.59	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	74.88	5.91	1.97
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	85.47	6.81	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	108.40	5.62	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	101.42	5.60	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	136.24	7.01	1.00
Cardiac Myocyte, donor1	11525-119I4	25.59	5.48	0.00
Cardiac Myocyte, donor2	11605-120I3	19.76	1.48	0.00
Cardiac Myocyte, donor3	11686-122I3	35.46	4.10	0.53
Chondrocyte - de diff, donor1	11261-116G1	35.01	5.89	1.04
Chondrocyte - de diff, donor2	11338-117F6	17.77	3.55	1.42
Chondrocyte - de diff, donor3	11410-118E6	29.24	4.55	0.34
Chondrocyte - re diff, donor2	11339-117F7	62.67	3.58	0.90
Chondrocyte - re diff, donor3	11411-118E7	24.26	3.24	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	44.76	13.54	2.30
Ciliary Epithelial Cells, donor2	11323-117D9	26.29	5.13	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	30.18	5.13	1.24
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	18.43	3.48	0.83
Corneal Epithelial Cells, donor1	11526-119I5	8.78	0.44	0.22
Corneal Epithelial Cells, donor2	11606-120I4	11.38	2.28	2.28
Corneal Epithelial Cells, donor3	11687-122I4	15.85	1.02	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.51	7.43	1.32
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	11.99	6.94	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	6.90	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	9.94	4.64	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	138.36	56.03	5.81
Dendritic Cells - plasmacytoid, donor2	11309-117C4	169.75	73.77	7.83
Dendritic Cells - plasmacytoid, donor3	11385-118B8	188.25	59.04	6.78
Endothelial Cells - Aortic, donor0	11207-116A1	22.51	3.50	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	16.43	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	16.97	3.68	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	14.94	1.57	1.18
Endothelial Cells - Artery, donor1	11264-116G4	12.22	3.20	0.00
Endothelial Cells - Artery, donor2	11341-117F9	26.35	2.82	0.00
Endothelial Cells - Artery, donor3	11413-118E9	15.43	2.63	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	18.18	6.43	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	20.99	9.13	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	26.50	7.89	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	10.70	3.57	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	17.70	4.69	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.66	1.56	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	48.01	6.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	9.96	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	69.33	10.93	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	41.93	3.69	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	55.20	5.13	0.61
Endothelial Cells - Vein, donor1	11267-116G7	7.96	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	10.48	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	19.00	0.47	0.31
Eosinophils, donor1	12244-129H3	350.68	15.25	0.00
Eosinophils, donor2	12245-129H4	417.52	56.11	0.00
Eosinophils, donor3	12246-129H5	274.65	42.80	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	8.55	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	4.16	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	21.35	2.05	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.85	4.27	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	20.69	6.18	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	41.84	6.67	0.85
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	25.38	7.64	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	18.88	3.48	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	19.23	4.22	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	32.56	3.99	0.00
Fibroblast - Cardiac, donor1	11268-116G8	19.96	3.63	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	2.27	0.76
Fibroblast - Cardiac, donor3	11417-118F4	11.04	2.21	0.47
Fibroblast - Cardiac, donor4	11452-119A3	30.61	8.49	1.82
Fibroblast - Cardiac, donor5	11456-119A7	30.71	2.54	0.89
Fibroblast - Cardiac, donor6	11460-119B2	25.01	3.34	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	15.68	4.56	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	15.53	5.61	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	30.76	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	41.28	2.77	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	32.90	15.43	1.70
Fibroblast - Dermal, donor1	11269-116G9	20.19	3.76	0.23
Fibroblast - Dermal, donor2	11346-117G5	32.07	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	23.69	3.63	0.73
Fibroblast - Dermal, donor4	11450-119A1	52.57	4.63	0.45
Fibroblast - Dermal, donor5	11454-119A5	49.20	4.71	0.87
Fibroblast - Dermal, donor6	11458-119A9	44.18	3.74	0.81
Fibroblast - Gingival, donor1	11237-116D4	33.73	6.25	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	32.23	9.69	1.57
Fibroblast - Gingival, donor2	11318-117D4	36.77	1.98	1.45
Fibroblast - Gingival, donor3	11394-118C8	32.39	7.25	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	31.17	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.49	3.17	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	38.04	8.26	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	25.96	3.65	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	6.00	1.06	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	31.88	5.56	0.88
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	34.77	9.54	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	51.12	10.09	1.21
Fibroblast - Gingival, donor9 (control)	11927-125I1	37.71	5.87	0.73
Fibroblast - Lung, donor1	11270-116H1	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	41.78	11.94	0.00
Fibroblast - Lung, donor3	11419-118F6	17.09	1.48	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	21.66	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	8.39	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	4.20	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	24.36	4.87	0.00
Fibroblast - Mammary, donor2	11620-122A9	7.99	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	52.57	3.88	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	51.72	4.25	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	43.76	8.26	2.14
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	30.15	3.05	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.59	3.78	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.09	1.62	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	54.27	6.52	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	22.76	1.22	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	10.69	2.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	20.95	4.35	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	31.55	9.33	1.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	38.54	7.82	1.24
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	44.54	4.73	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	21.36	6.02	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	53.33	10.90	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	30.88	5.31	0.76
Fibroblast - skin normal, donor1	11553-120C5	33.47	4.92	1.15
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	41.91	7.82	1.20
Fibroblast - skin normal, donor2	11561-120D4	55.25	5.63	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	27.81	10.28	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	40.43	9.03	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	42.91	13.85	2.05
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.93	5.91	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	51.13	6.71	0.85
Fibroblast - skin walker warburg, donor1	11554-120C6	38.63	5.23	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	42.50	10.19	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	819.91	88.64	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	44.45	20.92	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	19.59	5.37	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	36.17	3.64	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	28.36	4.85	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	47.46	13.78	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	45.94	13.40	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	85.86	15.12	3.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	48.81	9.65	3.58
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	26.03	5.48	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	44.98	9.71	3.37
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.35	8.46	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	31.31	6.20	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	80.04	10.17	3.10
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	68.40	23.46	5.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	49.63	11.94	3.32
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	55.34	16.65	3.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	53.65	4.83	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	59.25	7.48	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	53.47	7.93	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.86	5.25	2.28
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	42.60	6.73	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	41.75	6.56	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	31.03	6.50	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	43.55	5.72	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	38.88	8.49	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	26.01	5.65	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	45.29	5.26	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	66.42	11.53	2.93
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	54.84	14.98	2.19
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	58.92	21.35	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	37.84	6.97	1.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	54.99	10.57	2.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	59.21	10.00	1.63
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.56	6.81	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	39.43	5.88	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	33.19	3.34	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	26.67	8.16	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	40.46	8.86	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	31.93	6.81	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	35.92	6.74	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	25.87	3.79	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	26.26	5.38	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	24.02	5.78	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	30.73	4.08	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	25.25	5.49	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	26.09	4.21	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	28.52	5.37	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	27.81	3.21	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	25.40	5.05	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.15	4.40	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	22.23	4.61	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.65	5.53	1.11
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.00	7.46	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	30.74	9.92	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.85	6.33	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	21.59	3.63	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	42.95	16.01	3.05
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	104.71	30.85	8.36
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	62.86	20.95	4.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	82.86	30.07	4.50
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	41.31	8.14	1.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	44.08	11.02	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	63.65	6.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	74.24	14.85	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	64.98	13.15	3.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	43.32	6.42	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	46.95	8.69	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	54.68	11.39	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	63.42	14.41	4.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	53.32	19.99	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	46.98	9.23	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	60.47	8.50	4.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	42.78	7.55	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	47.71	8.59	2.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	58.76	10.19	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	6.26	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	60.13	7.45	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	26.93	6.22	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	10.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	53.85	15.33	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	46.95	12.89	3.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	15.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	38.83	8.07	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	38.79	10.11	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	29.43	9.36	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	52.01	7.32	3.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	63.33	18.83	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	19.88	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	49.07	10.85	3.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	53.11	8.45	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	49.85	11.70	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	51.45	11.17	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	60.68	16.77	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	51.94	11.80	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	47.84	11.09	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	64.08	12.29	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	55.95	15.26	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	33.43	5.97	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	37.36	10.68	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	10.27	2.28	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.89	3.33	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	4.50	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	18.08	7.93	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	12.95	5.43	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	48.27	4.41	1.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	45.41	3.88	1.35
Hep-2 cells mock treated, biol_rep3	11900-125F1	56.65	4.78	1.82
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	47.55	5.36	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	52.65	5.80	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	51.02	4.74	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	43.71	4.23	0.75
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	38.08	3.43	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	37.16	5.13	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	7.83	2.24	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	12.12	1.73	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	2.64	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.64	2.82	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.99	2.18	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	36.72	3.85	0.17
Hepatocyte, donor1	11523-119I2	15.74	3.63	0.00
Hepatocyte, donor2	11603-120I1	29.09	8.62	0.00
Hepatocyte, donor3	11684-122I1	29.45	6.75	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	56.13	22.84	4.57
Intestinal epithelial cells (polarized), donor1	11246-116E4	55.58	8.21	2.27
Iris Pigment Epithelial Cells, donor1	11530-119I9	38.56	6.59	1.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	4.15	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	10.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	22.74	6.50	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	16.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	7.26	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	6.62	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	3.33	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	26.19	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	20.16	3.78	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	13.92	6.19	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	22.61	7.11	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	6.44	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	10.59	4.89	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	9.24	2.94	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	15.27	5.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	2.77	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	16.05	3.30	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	13.60	6.35	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	16.14	4.30	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	12.70	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	14.67	2.55	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	9.11	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	11.43	4.28	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	6.64	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	18.83	3.09	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	11.82	2.09	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	9.00	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	9.60	2.13	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	13.85	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	12.89	4.60	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	9.08	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	12.69	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	18.03	2.61	0.49
Keratinocyte - epidermal, donor2	11349-117G8	21.08	1.76	0.00
Keratinocyte - epidermal, donor3	11421-118F8	48.27	2.46	0.95
Keratinocyte - oral, donor1	11251-116E9	63.80	9.08	2.04
Keratocytes, donor1	11527-119I6	42.64	1.38	0.34
Keratocytes, donor2	11607-120I5	9.37	0.00	0.00
Keratocytes, donor3	11688-122I5	35.17	2.17	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	142.86	19.78	2.20
Lens Epithelial Cells, donor1	11529-119I8	25.89	5.39	1.08
Lens Epithelial Cells, donor2	11609-120I7	34.60	10.61	1.96
Lens Epithelial Cells, donor3	11690-122I7	35.42	7.87	0.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.43	4.86	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	19.26	2.23	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.19	8.03	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	17.74	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	13.55	1.58	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	10.35	3.02	0.65
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	27.91	3.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	9.10	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.39	2.82	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.57	2.37	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	22.49	3.30	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	6.11	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	22.30	3.14	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	13.12	1.43	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	13.32	2.88	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.79	2.46	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	10.60	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	10.43	3.29	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	15.47	2.30	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	7.32	1.76	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	8.71	2.24	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	30.55	4.36	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	22.62	3.23	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	16.20	3.18	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.07	4.15	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.43	3.35	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	12.03	3.76	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	18.57	3.44	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	20.88	2.82	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	7.74	1.91	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	17.93	3.39	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	16.54	2.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	7.56	2.11	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	25.54	7.77	1.48
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	19.52	2.72	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	7.70	2.34	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	29.59	4.82	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	28.91	3.65	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	18.48	3.50	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	21.33	2.84	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	14.06	2.91	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	6.69	2.33	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.49	4.30	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	12.41	1.31	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	5.65	1.18	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	19.43	4.33	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	9.73	1.28	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.93	2.09	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	6.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	20.71	12.27	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	26.72	11.13	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	17.77	12.69	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	4.92	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	11.21	8.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	7.73	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	4.76	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.23	11.76	1.81
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	32.28	19.19	1.16
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.21	22.06	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	22.76	12.46	1.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	22.08	10.27	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	24.70	13.41	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.99	24.65	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	21.90	11.21	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	31.48	17.88	1.60
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	34.39	15.30	2.46
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	15.34	7.98	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	22.02	4.89	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	36.23	14.99	2.50
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.99	16.82	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	9.27	3.09
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	27.00	13.35	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	28.40	11.96	2.99
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	35.41	12.72	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.03	11.31	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	29.87	9.22	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	17.27	4.61	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	28.78	11.90	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.42	7.93	2.26
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	26.25	9.03	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.27	5.42	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	21.54	12.21	1.44
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	23.90	9.71	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	22.67	6.69	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	28.00	10.77	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	7.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	20.66	11.66	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	16.89	7.24	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	14.22	7.11	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	21.65	9.97	2.06
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	24.15	8.59	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	15.49	7.41	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.93	9.63	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	29.07	12.79	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	3.17	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.01	9.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	18.90	2.91	3.63
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	14.56	13.03	3.07
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	19.73	11.35	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	13.17	2.82
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	12.57	7.04	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	21.18	9.91	2.25
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	8.61	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	19.15	12.91	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14.08	5.08	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	16.49	6.60	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	17.12	8.30	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	28.88	7.00	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	31.31	14.54	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	22.08	6.62	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	24.30	10.41	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	21.27	9.62	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	30.76	7.69	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	29.42	11.13	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	26.13	9.11	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.13	9.68	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	22.04	8.74	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	30.99	10.33	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	21.77	4.23	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.67	4.75	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	27.19	6.40	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	27.58	8.05	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	21.60	7.71	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	28.29	6.37	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.94	5.67	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	31.62	8.74	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	21.14	4.70	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.65	4.59	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	24.63	6.50	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	22.75	4.01	1.34
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	24.06	3.21	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	27.07	7.27	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	17.44	4.59	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	14.23	4.45	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	23.36	5.70	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	20.71	7.67	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	21.89	4.92	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	22.72	4.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	26.26	5.46	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	19.23	4.64	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	15.95	11.17	2.28
Macrophage - monocyte derived, donor2	11313-117C8	12.85	3.67	0.92
Macrophage - monocyte derived, donor3	11389-118C3	13.76	3.67	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	28.68	4.25	1.06
Mallassez-derived cells, donor2	11929-125I3	37.39	8.56	1.90
Mallassez-derived cells, donor3	11930-125I4	56.15	11.12	2.22
Mammary Epithelial Cell, donor1	11273-116H4	92.47	8.97	1.20
Mammary Epithelial Cell, donor2	11350-117G9	82.81	6.37	0.58
Mammary Epithelial Cell, donor3	11422-118F9	12.47	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	446.76	42.71	2.03
Mast cell, donor1	11563-120D6	44.66	21.63	2.92
Mast cell, donor2	11565-120D8	137.29	24.96	4.16
Mast cell, donor3	11566-120D9	151.28	27.47	2.70
Mast cell, donor4	11567-120E1	117.54	24.29	2.13
Mast cell, expanded and stimulated, donor5	11940-126A5	38.48	18.96	3.44
Mast cell, expanded and stimulated, donor8	11942-126A7	36.77	23.93	3.50
Mast cell, expanded, donor5	11939-126A4	37.74	15.37	2.18
Mast cell, expanded, donor8	11941-126A6	30.13	37.32	3.35
Melanocyte - dark, donor1	11502-119F8	32.93	12.14	1.29
Melanocyte - dark, donor2	11582-120F7	21.11	4.50	0.69
Melanocyte - dark, donor3	11663-122F7	35.79	8.91	1.96
Melanocyte - light, donor1	11274-116H5	6.11	1.65	0.47
Melanocyte - light, donor2	11351-117H1	4.78	2.05	1.36
Melanocyte - light, donor3	11423-118G1	8.67	2.60	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	30.40	3.85	1.25
Melanocyte, donor2 (MC+2)	12739-135I3	23.40	4.84	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	24.11	8.04	1.61
Meningeal Cells, donor1	11493-119E8	34.24	4.59	0.37
Meningeal Cells, donor2	11573-120E7	19.37	3.08	0.44
Meningeal Cells, donor3	11654-122E7	54.52	7.01	1.47
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	37.93	3.71	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	34.72	9.26	1.51
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	3.94	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	38.75	5.74	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	28.17	5.51	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	16.08	3.02	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.02	1.98	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	19.00	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	11.66	1.02	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	32.41	10.11	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	7.43	1.86	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	36.84	8.95	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	17.80	4.15	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	25.62	1.28	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	74.79	5.32	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	33.15	6.57	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	37.74	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	19.89	3.71	0.27
Mesothelial Cells, donor2	12156-128G5	18.02	1.50	0.00
Mesothelial Cells, donor3	11402-118D7	14.67	1.45	0.43
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	22.96	22.96	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	15.27	9.60	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	10.60	4.12	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.09	7.13	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.37	4.77	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.27	6.51	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.64	6.05	1.40
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	10.16	4.67	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	7.13	3.56	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	12.39	6.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	11.40	6.46	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	5.26	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	10.82	4.88	1.49
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	3.68	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	9.24	1.79	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	11.04	2.51	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	13.78	2.14	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	16.03	2.76	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.27	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	13.25	2.10	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.64	2.24	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	17.59	3.86	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	15.12	1.33	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.11	0.88	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	12.17	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	18.21	3.53	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.23	2.06	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	13.46	2.88	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	16.81	2.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	20.57	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	22.53	2.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	15.33	0.88	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	9.93	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	11.53	2.56	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	25.54	2.48	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	2.78	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.28	5.81	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	2.19	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.49	1.42	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	17.11	4.77	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.04	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	11.65	2.33	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.76	1.51	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	11.27	2.92	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	20.32	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.94	4.55	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.99	3.32	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	14.25	4.15	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	10.72	4.29	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	12.70	5.08	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	18.15	3.74	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	18.86	4.79	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.42	4.66	0.85
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	16.56	4.46	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	12.60	5.09	1.33
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.76	1.90	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	5.68	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	12.54	4.92	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.03	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.82	3.53	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	13.84	3.75	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.49	9.07	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	14.29	2.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	15.07	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	19.60	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.10	11.17	2.96
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	9.47	8.42	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	9.09	16.21	2.97
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.04	13.97	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.51	12.77	4.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	9.06	5.59	1.07
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	22.28	17.87	3.39
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	2.95	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	10.63	9.16	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1.56	6.22	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	33.67	13.90	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	8.08	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	10.96	5.48	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	32.69	4.09	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	12.08	5.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	20.25	3.24	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	13.05	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	36.19	6.25	1.72
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	28.22	4.70	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	5.84	3.76	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	44.11	3.80	0.57
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	68.62	11.17	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	3.40	2.04	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	170.90	11.03	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	5.86	1.67	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	11.39	5.35	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	6.22	2.43	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	21.65	6.52	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	311.77	33.40	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.93	6.45	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.24	6.50	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.21	3.40	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	7.68	2.45	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	19.32	5.29	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	7.43	2.12	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1.80	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	40.04	16.08	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	4.55	1.79	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.40	7.23	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	7.74	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	7.36	2.30	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.00	3.53	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.42	7.59	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	230.09	20.23	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.28	4.46	0.89
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	4.66	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.24	2.85	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.01	4.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	261.81	72.22	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	8.33	3.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	12.17	2.25	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	7.14	1.19	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3.71	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.13	4.54	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	3.58	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	4.79	2.18	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	23.97	4.98	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.06	6.17	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	3.99	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	5.95	3.97	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	6.51	2.30	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	16.63	1.81	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	25.64	3.54	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	158.40	25.55	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	6.71	1.83	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.98	2.20	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	5.75	1.21	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	6.33	2.37	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	45.35	4.53	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	222.55	15.17	5.06
Myoblast, donor1	11241-116D8	31.80	3.35	0.50
Myoblast, donor2	11322-117D8	25.70	5.18	0.19
Myoblast, donor3	11398-118D3	39.18	5.89	1.18
NK T cell leukemia cell line:KHYG-1	10777-110G3	40.86	10.51	1.31
Natural Killer Cells, donor1	11230-116C6	168.21	72.88	6.15
Natural Killer Cells, donor2	11311-117C6	115.50	41.61	3.92
Natural Killer Cells, donor3	11387-118C1	113.19	45.09	2.94
Neural stem cells, donor1	11275-116H6	54.44	20.69	1.09
Neural stem cells, donor2	11352-117H2	88.58	19.26	7.70
Neurons, donor1	11494-119E9	67.14	7.97	0.00
Neurons, donor2	11574-120E8	54.38	5.50	0.44
Neurons, donor3	11655-122E8	46.04	8.22	1.64
Neutrophils, donor1	11233-116C9	168.90	35.26	2.78
Neutrophils, donor2	11314-117C9	104.36	8.70	0.00
Neutrophils, donor3	11390-118C4	158.82	40.32	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	36.10	8.19	0.95
Nucleus Pulposus Cell, donor2	11409-118E5	11.40	3.26	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	18.85	1.80	0.40
Olfactory epithelial cells, donor1	11933-125I7	11.84	5.09	0.96
Olfactory epithelial cells, donor2	11934-125I8	23.30	7.67	1.01
Olfactory epithelial cells, donor3	11935-125I9	16.00	6.13	0.68
Olfactory epithelial cells, donor4	11936-126A1	17.53	4.48	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	52.96	3.01	1.20
Osteoblast - differentiated, donor1	11276-116H7	16.38	5.96	0.43
Osteoblast - differentiated, donor2	11353-117H3	13.72	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	15.52	8.69	0.00
Osteoblast, donor1	11277-116H8	17.98	3.91	0.20
Osteoblast, donor2	11354-117H4	65.32	5.62	1.40
Osteoblast, donor3	11426-118G4	17.42	1.96	0.53
Pancreatic stromal cells, donor1	11249-116E7	32.26	6.65	0.93
Pericytes, donor1	11491-119E6	6.79	0.78	0.00
Pericytes, donor2	11571-120E5	4.75	0.91	0.00
Pericytes, donor3	11652-122E5	9.36	0.81	0.20
Perineurial Cells, donor1	11499-119F5	41.14	7.12	0.57
Perineurial Cells, donor2	11579-120F4	33.22	6.35	1.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	186.78	65.98	6.06
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	107.98	37.71	2.69
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	91.76	24.98	1.68
Placental Epithelial Cells, donor1	11278-116H9	17.46	2.39	0.48
Placental Epithelial Cells, donor2	11355-117H5	14.42	5.54	1.11
Placental Epithelial Cells, donor3	11427-118G5	9.23	2.55	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	25.95	3.16	0.32
Preadipocyte - breast, donor1	11467-119B9	34.14	8.07	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	31.85	6.53	0.52
Preadipocyte - breast, donor2	11328-117E5	26.57	5.18	0.90
Preadipocyte - omental, donor1	11468-119C1	38.57	7.35	1.60
Preadipocyte - omental, donor2	11329-117E6	34.04	6.98	0.87
Preadipocyte - omental, donor3	11403-118D8	27.50	5.01	0.86
Preadipocyte - perirenal, donor1	11469-119C2	20.67	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	16.28	3.38	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	55.60	3.72	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	37.12	6.64	0.68
Preadipocyte - visceral, donor1	11280-116I2	66.69	6.89	1.21
Preadipocyte - visceral, donor2	11357-117H7	35.89	5.52	1.38
Preadipocyte - visceral, donor3	11429-118G7	34.69	2.93	0.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	65.77	4.83	1.51
Prostate Epithelial Cells, donor2	11331-117E8	13.68	3.39	0.81
Prostate Epithelial Cells, donor3	11404-118D9	33.13	2.39	0.73
Prostate Stromal Cells, donor1	11254-116F3	51.94	2.62	0.91
Prostate Stromal Cells, donor2	11332-117E9	34.60	2.51	0.90
Prostate Stromal Cells, donor3	11405-118E1	21.27	3.44	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	19.34	2.19	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	37.22	4.64	0.83
Renal Epithelial Cells, donor1	11517-119H5	12.17	1.01	0.00
Renal Epithelial Cells, donor2	11597-120H4	11.38	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	44.04	7.20	1.48
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.77	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	11.19	1.08	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	41.74	5.99	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	1.33	0.00
Renal Mesangial Cells, donor1	11518-119H6	11.44	1.54	0.00
Renal Mesangial Cells, donor2	11598-120H5	8.15	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.83	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	40.53	4.56	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	14.76	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.04	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	46.15	3.11	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	18.48	2.56	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	16.47	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	71.26	9.53	2.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	46.10	13.10	2.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	33.06	5.36	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	46.78	14.31	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	81.21	20.88	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	57.99	8.06	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	28.30	3.28	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	44.06	5.24	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	61.65	7.44	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	38.23	6.06	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	42.99	4.62	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	36.42	4.79	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	36.46	4.54	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	40.50	7.35	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	28.69	4.59	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	35.63	4.72	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	34.52	7.52	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	29.06	8.22	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	32.51	6.52	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	46.60	15.97	3.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	35.43	9.02	1.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	35.72	5.55	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	38.38	9.17	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	33.43	7.05	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	28.87	7.29	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	34.35	6.67	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	31.36	4.56	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.17	6.99	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	41.64	6.31	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	37.50	8.02	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	28.37	11.51	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	32.97	7.02	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	28.82	6.84	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	32.08	10.40	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	30.50	6.06	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	37.41	6.59	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	36.78	6.81	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	32.97	5.40	0.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	40.92	4.47	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	36.76	4.39	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	36.28	7.55	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	25.56	3.92	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	34.03	5.92	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	39.72	2.40	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	29.31	3.87	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	30.48	2.38	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	33.05	6.05	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	31.36	4.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	38.78	8.73	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	31.73	5.14	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	29.25	4.41	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	49.63	14.56	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	29.81	4.26	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	27.73	5.73	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	29.18	4.52	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	28.16	5.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	44.75	6.97	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	24.33	3.84	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	24.04	7.81	0.60
Schwann Cells, donor1	11498-119F4	10.34	0.75	0.00
Schwann Cells, donor2	11578-120F3	20.41	6.80	0.00
Schwann Cells, donor3	11659-122F3	23.88	2.85	0.00
Sebocyte, donor1	11220-116B5	36.70	2.74	0.00
Sebocyte, donor2	11301-117B5	25.74	1.84	0.46
Sebocyte, donor3	11378-118B1	10.92	1.24	0.41
Sertoli Cells, donor1	11255-116F4	33.13	8.28	3.31
Sertoli Cells, donor2	11333-117F1	16.95	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	33.17	5.98	1.23
Skeletal Muscle Cells, donor2	11358-117H8	6.51	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	15.05	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	47.29	4.40	0.79
Skeletal Muscle Cells, donor5	11455-119A6	42.36	5.05	1.19
Skeletal Muscle Cells, donor6	11459-119B1	58.64	4.16	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	49.14	17.01	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	30.11	5.99	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	52.48	3.37	0.99
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	29.32	8.59	1.18
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.03	2.17	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.02	2.20	0.69
Skin - palm, donor1	10286-104F7	69.84	8.06	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.40	1.73	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	62.98	17.18	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	13.76	2.08	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	59.08	7.37	1.67
Small Airway Epithelial Cells, donor2	11334-117F2	36.29	3.80	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	58.78	8.88	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	39.12	2.70	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	22.84	4.32	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	16.90	3.11	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	17.63	2.94	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	15.25	2.21	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.27	1.58	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	14.68	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	33.02	14.01	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	13.31	1.86	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	26.60	3.32	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	19.72	3.71	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	26.05	5.21	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	24.51	5.32	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	15.23	2.42	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	5.69	0.81	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.18	2.74	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.67	4.29	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	8.11	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.21	3.69	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	28.41	3.66	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	30.75	2.83	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	14.23	2.78	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	14.05	2.39	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	8.88	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.42	10.92	1.26
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	21.74	3.22	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.80	3.41	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	6.64	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	109.68	7.95	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	50.87	5.33	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	41.32	4.01	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	19.28	5.58	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	23.22	4.67	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	9.75	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2.58	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	12.56	3.26	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	13.63	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	8.78	1.57	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	7.67	0.88	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	56.98	5.08	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	23.83	5.61	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	12.23	2.45	0.58
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	14.53	2.29	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	9.03	0.75	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	60.65	7.83	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	43.82	5.53	0.59
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	13.95	1.71	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	38.67	6.19	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	38.91	7.61	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	20.80	2.33	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.25	2.38	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	24.92	5.95	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.79	2.52	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	18.74	3.12	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	40.57	6.30	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	28.19	5.84	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	20.37	3.19	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	23.41	1.67	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	27.50	4.13	0.46
Synoviocyte, donor1	11291-117A4	38.38	8.42	1.35
Synoviocyte, donor2	11368-117I9	24.81	6.37	0.50
Synoviocyte, donor3	11440-118H9	17.87	6.26	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	22.87	2.86	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	17.84	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.36	0.93	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	37.49	3.94	0.86
Tracheal Epithelial Cells, donor2	11369-118A1	10.82	1.93	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	12.03	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	43.18	12.30	2.09
Urethra, donor2	10319-105A4	19.78	25.18	0.00
Urothelial Cells, donor1	11520-119H8	7.17	0.00	0.27
Urothelial Cells, donor2	11600-120H7	6.41	1.20	0.00
Urothelial Cells, donor3	11681-122H7	9.40	0.69	0.46
Urothelial cells, donor0	11216-116B1	35.89	7.58	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	48.05	30.25	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	45.75	27.16	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	25.33	9.58	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	36.50	29.27	4.82
Whole blood (ribopure), donor090325, donation2	12177-128I8	49.97	23.24	4.07
Whole blood (ribopure), donor090612, donation1	12182-129A4	63.52	28.11	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	66.08	38.55	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	25.56	9.13	1.83
Wilms' tumor cell line:G-401	10809-111A8	49.22	8.76	2.59
Wilms' tumor cell line:HFWT	10597-108E3	62.48	7.92	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	44.69	5.03	1.96
achilles tendon, donor2	10292-104G4	35.13	8.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	113.46	14.28	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	119.11	16.02	5.57
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	104.82	15.55	3.44
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	155.92	10.88	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	71.40	10.40	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	71.48	21.36	5.71
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	74.04	32.94	4.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	63.45	22.91	3.53
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	47.78	16.33	2.45
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	38.44	15.53	4.27
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	114.45	9.20	2.58
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	19.50	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	51.12	15.10	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	93.72	19.68	3.88
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	67.80	13.44	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	59.49	10.22	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	54.70	9.87	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.02	5.22	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	75.10	17.07	3.84
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.68	21.23	2.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	98.45	21.90	5.78
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	69.05	11.14	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	62.37	9.34	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	280.59	16.72	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	105.09	21.85	4.14
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	61.06	13.96	3.49
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	103.10	20.62	5.62
adenocarcinoma cell line:IM95m	10796-110I4	27.79	20.72	5.18
adipose tissue, adult, pool1	10010-101C1	35.68	6.98	0.62
adipose, donor1	10184-103D4	117.28	28.15	9.38
adipose, donor2	10185-103D5	17.84	2.43	1.62
adipose, donor3	10186-103D6	24.51	4.36	1.09
adipose, donor4	10187-103D7	45.07	7.80	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	35.51	10.89	2.84
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	36.95	4.80	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	57.53	6.79	0.71
amniotic membrane cells, donor1	12235-129G3	35.94	10.43	1.62
amniotic membrane cells, donor2	12236-129G4	45.64	10.14	3.38
amniotic membrane cells, donor3	12237-129G5	37.12	13.85	1.77
amygdala - adult, donor10196	10167-103B5	35.57	10.67	1.19
amygdala, adult, donor10252	10151-102I7	32.44	11.15	2.84
amygdala, newborn, donor10223	10360-105E9	27.76	2.90	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	82.76	20.37	1.91
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	42.36	8.38	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	48.44	5.01	1.34
aorta, adult, pool1	10052-101G7	9.61	2.94	0.39
appendix, adult	10189-103D9	36.87	19.79	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	54.00	32.33	5.16
artery, adult	10190-103E1	25.82	17.66	1.36
astrocytoma cell line:TM-31	10425-106D2	67.36	11.30	3.04
b cell line:RPMI1788	10427-106D4	73.46	16.95	1.49
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.74	5.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	68.87	14.79	2.58
bile duct carcinoma cell line:TFK-1	10496-107C1	88.54	9.54	2.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	37.47	26.84	2.24
bladder, adult, pool1	10011-101C2	49.54	11.52	1.20
blood, adult, pool1	10053-101G8	28.79	8.86	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	44.53	15.41	0.00
bone marrow, adult	10192-103E3	53.31	8.77	1.35
brain, adult, donor1	10084-102B3	4.10	2.05	0.00
brain, adult, pool1	10012-101C3	34.97	9.80	2.90
brain, fetal, pool1	10085-102B4	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	116.95	23.13	6.61
breast carcinoma cell line:MDA-MB-453	10419-106C5	92.49	16.35	3.74
breast, adult, donor1	10080-102A8	19.57	3.79	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	56.91	14.36	4.19
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	47.00	6.80	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	73.44	5.53	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	38.25	7.26	0.97
carcinoid cell line:NCI-H1770	10703-109H1	40.43	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	61.69	16.08	2.84
carcinoid cell line:SK-PN-DW	10719-109I8	52.29	15.21	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	93.16	13.04	2.13
caudate nucleus - adult, donor10196	10177-103C6	56.41	13.82	0.00
caudate nucleus, adult, donor10252	10164-103B2	40.16	6.36	3.01
caudate nucleus, adult, donor10258	10379-105H1	32.09	11.46	1.53
caudate nucleus, newborn, donor10223	10354-105E3	30.76	6.96	0.73
cerebellum - adult, donor10196	10173-103C2	75.75	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	67.04	13.88	3.63
cerebellum, adult, pool1	10083-102B2	18.28	4.83	1.03
cerebellum, newborn, donor10223	10357-105E6	48.99	12.45	1.66
cerebral meninges, adult	10188-103D8	49.42	8.57	0.76
cerebrospinal fluid, donor2	10294-104G6	23.39	8.04	0.00
cervical cancer cell line:D98-AH2	10552-107I3	62.98	14.23	3.74
cervical cancer cell line:ME-180	10553-107I4	49.71	8.95	2.15
cervix, adult, pool1	10013-101C4	41.79	15.75	2.41
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	54.48	5.43	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	5.23	3.92
choriocarcinoma cell line:BeWo	10423-106C9	100.42	12.80	2.24
choriocarcinoma cell line:SCH	10785-110H2	59.02	7.27	1.60
choriocarcinoma cell line:T3M-3	10618-108G6	63.33	12.81	2.13
chorionic membrane cells, donor1	12238-129G6	46.44	7.41	1.14
chorionic membrane cells, donor2	12239-129G7	42.66	3.28	1.19
chorionic membrane cells, donor3	12240-129G8	39.01	7.14	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	65.64	13.13	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	41.30	13.83	2.50
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	46.25	3.17	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	78.07	12.58	2.05
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	75.71	14.51	2.18
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	85.72	14.05	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	119.25	25.03	9.13
chronic myelogenous leukemia cell line:KU812	10409-106B4	68.02	25.54	3.91
clear cell carcinoma cell line:JHOC-5	10638-108I8	61.72	7.31	2.06
clear cell carcinoma cell line:TEN	10636-108I6	92.13	11.80	1.21
colon carcinoma cell line:CACO-2	10513-107D9	64.98	11.71	2.56
colon carcinoma cell line:COLO-320	10420-106C6	184.72	30.41	2.66
colon, adult, donor1	10082-102B1	1.19	2.38	1.19
colon, adult, pool1	10014-101C5	37.13	19.74	3.76
colon, fetal, donor1	10070-101I7	16.07	11.12	1.24
common myeloid progenitor CMP, donor1	12130-128D6	187.92	32.08	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	164.02	24.65	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	109.73	21.13	4.23
cord blood derived cell line:COBL-a untreated	10449-106F8	117.89	18.47	3.67
corpus callosum, adult, pool1	10042-101F6	27.20	10.61	3.76
cruciate ligament, donor2	10295-104G7	44.58	9.73	0.00
diaphragm, fetal, donor1	10069-101I6	15.25	8.83	4.82
diencephalon, adult	10193-103E4	19.44	7.68	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	106.77	27.32	4.82
ductal cell carcinoma cell line:KLM-1	10438-106E6	127.19	13.59	2.56
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	84.25	9.15	1.69
ductus deferens, adult	10196-103E7	19.44	5.48	2.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	10.08	10.08	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	36.78	13.24	2.94
dura mater, adult, donor1	10041-101F5	36.42	10.41	1.57
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	116.59	41.31	6.66
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	92.14	17.77	3.58
embryonic pancreas cell line:1B2C6	10604-108F1	106.06	4.93	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	72.95	5.15	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	106.52	8.34	1.54
embryonic pancreas cell line:2C6	10603-108E9	136.60	9.19	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	122.68	11.40	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	90.80	10.33	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	23.48	8.04	1.29
epidermoid carcinoma cell line:A431	10426-106D3	100.27	5.11	1.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	68.96	7.48	3.74
epididymis, adult	10197-103E8	26.79	9.63	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	46.13	11.71	1.77
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	33.43	5.90	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	68.54	6.68	2.23
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	73.42	12.89	4.04
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	69.46	6.27	1.46
esophagus, adult, pool1	10015-101C6	29.20	9.45	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	134.75	32.06	2.38
eye - muscle inferior rectus, donor1	10272-104E2	41.05	7.24	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	12.63	0.00
eye - muscle medial, donor2	10299-104H2	26.79	8.93	1.49
eye - muscle superior, donor2	10297-104G9	41.27	5.73	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	4.37	0.00
eye, fetal, donor1	10054-101G9	20.34	8.39	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	35.77	10.13	2.44
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	54.13	3.32	0.00
frontal lobe, adult, pool1	10040-101F4	41.47	15.39	2.63
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	88.57	20.12	7.51
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	60.17	8.78	1.46
gall bladder, adult	10198-103E9	20.52	8.93	0.97
gamma delta positive T cells, donor1	11937-126A2	74.09	31.67	4.29
gamma delta positive T cells, donor2	11938-126A3	98.23	31.00	3.73
gastric adenocarcinoma cell line:MKN1	10614-108G2	54.49	5.49	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	40.81	8.90	2.51
gastric cancer cell line:AZ521	10549-107H9	127.07	30.17	4.59
gastric cancer cell line:GSS	10560-108A2	79.62	18.30	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	65.11	10.74	2.74
giant cell carcinoma cell line:LU65	10487-107B1	101.32	6.20	2.18
giant cell carcinoma cell line:Lu99B	10433-106E1	78.80	7.14	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	54.62	8.73	5.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	48.34	3.48	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	46.20	3.51	0.14
glioblastoma cell line:T98G	10485-107A8	37.42	4.97	0.55
glioma cell line:GI-1	10413-106B8	56.82	11.72	0.59
globus pallidus - adult, donor10196	10175-103C4	37.17	5.10	0.00
globus pallidus, adult, donor10252	10161-103A8	52.48	11.23	4.64
globus pallidus, adult, donor10258	10367-105F7	32.86	17.80	2.74
globus pallidus, newborn, donor10223	10364-105F4	25.05	4.26	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	183.54	26.92	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	10.45	5.23
granulosa cell tumor cell line:KGN	10624-108H3	25.92	6.40	1.28
hIPS +CCl2, biol_rep1	14383-156B9	57.85	8.72	1.38
hIPS +CCl2, biol_rep2	14384-156C1	62.19	7.32	1.83
hIPS +CCl2, biol_rep3	14385-156C2	61.83	7.73	0.64
hIPS, biol_rep1	14380-156B6	90.55	7.19	0.00
hIPS, biol_rep2	14381-156B7	50.07	6.17	2.06
hIPS, biol_rep3	14382-156B8	30.90	7.72	0.00
hairy cell leukemia cell line:Mo	10712-109I1	40.52	5.46	0.57
heart - mitral valve, adult	10205-103F7	34.98	10.46	1.49
heart - pulmonic valve, adult	10206-103F8	29.81	13.34	4.45
heart - tricuspid valve, adult	10207-103F9	54.95	5.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	16.12	4.29	1.22
heart, adult, diseased, donor1	10051-101G6	11.50	0.43	0.43
heart, adult, pool1	10016-101C7	27.83	8.05	1.84
heart, fetal, pool1	10046-101G1	33.99	13.96	2.36
hepatic mesenchymal tumor cell line:LI90	10778-110G4	19.13	3.09	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	122.49	52.32	5.95
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	77.02	8.95	3.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	77.44	8.01	3.16
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	83.47	9.70	3.33
hepatoma cell line:Li-7	10484-107A7	124.90	11.68	3.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	79.19	6.73	1.21
hippocampus - adult, donor10196	10169-103B7	36.91	4.73	0.00
hippocampus, adult, donor10252	10153-102I9	41.02	11.84	2.86
hippocampus, adult, donor10258	10374-105G5	31.37	7.97	0.50
hippocampus, newborn, donor10223	10363-105F3	19.39	7.40	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	96.43	29.30	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	57.53	12.57	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	62.20	12.19	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	25.94	14.10	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	39.25	14.20	3.61
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	41.76	15.56	4.56
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	31.24	9.63	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	32.31	9.05	1.51
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	36.29	12.51	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	49.02	14.21	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	29.25	8.52	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	50.50	16.16	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	47.73	9.39	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	64.36	13.76	4.42
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	101.24	20.95	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	44.67	9.16	3.82
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	38.81	8.72	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	46.48	8.50	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	31.27	5.27	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	30.92	4.55	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	33.52	5.33	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	24.50	7.68	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	28.16	8.42	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	29.59	3.59	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	41.01	13.49	2.40
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	39.37	13.41	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	75.95	11.43	2.04
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	39.43	6.34	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	23.76	6.65	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	27.54	7.87	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	32.06	5.17	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	25.24	10.63	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	33.35	6.93	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	26.59	8.18	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	22.72	9.09	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	24.20	9.41	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	36.47	7.00	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	68.63	19.61	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	46.83	14.63	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	27.20	7.03	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	257.01	58.56	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	47.66	14.89	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	31.20	6.57	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	28.95	6.15	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	37.37	6.05	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	20.29	7.16	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	41.17	8.40	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	26.67	5.39	1.35
immature langerhans cells, donor1	11904-125F5	124.22	10.90	1.45
immature langerhans cells, donor2	11905-125F6	73.67	5.54	0.00
insula, adult, pool1	10039-101F3	27.92	7.57	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	20.81	6.50	0.98
kidney, adult, pool1	10017-101C8	29.84	18.42	3.60
kidney, fetal, pool1	10045-101F9	28.58	5.23	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	109.64	18.18	5.11
large cell lung carcinoma cell line:NCI-H460	10839-111E2	47.14	10.09	1.66
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	57.80	10.28	2.39
left atrium, adult, donor1	10079-102A7	7.08	7.08	1.63
left ventricle, adult, donor1	10078-102A6	14.16	4.05	0.00
leiomyoblastoma cell line:G-402	10721-110A1	37.48	3.83	1.09
leiomyoma cell line:10964C	10569-108B2	12.57	3.23	0.72
leiomyoma cell line:15242A	10570-108B3	11.96	4.89	0.00
leiomyoma cell line:15425	10571-108B4	14.33	2.67	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	51.23	6.27	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	81.70	7.91	1.18
liposarcoma cell line:KMLS-1	10782-110G8	207.45	62.02	14.37
liposarcoma cell line:SW 872	10726-110A6	28.39	4.39	1.71
liver, adult, pool1	10018-101C9	24.80	6.00	1.78
liver, fetal, pool1	10086-102B5	2.82	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	34.12	7.87	1.90
locus coeruleus, adult, donor10252	10165-103B3	34.14	7.57	2.03
locus coeruleus, adult, donor10258	10375-105G6	14.67	9.03	1.97
locus coeruleus, newborn, donor10223	10362-105F2	37.86	10.52	1.68
lung adenocarcinoma cell line:A549	10499-107C4	46.09	13.70	3.88
lung adenocarcinoma cell line:PC-14	10408-106B3	72.39	13.10	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	82.39	9.36	1.71
lung, adult, pool1	10019-101D1	35.20	9.69	1.54
lung, fetal, donor1	10068-101I5	141.85	35.39	5.99
lung, right lower lobe, adult, donor1	10075-102A3	17.41	7.79	1.83
lymph node, adult, donor1	10077-102A5	17.51	10.89	0.00
lymphangiectasia cell line:DS-1	10727-110A7	32.00	12.49	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	65.20	12.98	4.38
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	128.27	27.18	5.95
mature adipocyte, donor1	12231-129F8	55.05	12.88	0.89
mature adipocyte, donor2	12232-129F9	52.92	8.51	1.66
mature adipocyte, donor3	12233-129G1	56.18	8.30	0.71
mature adipocyte, donor4	12234-129G2	107.92	20.00	2.90
maxillary sinus tumor cell line:HSQ-89	10414-106B9	141.05	30.74	7.62
medial frontal gyrus - adult, donor10196	10170-103B8	27.07	9.02	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	36.97	10.48	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	24.78	10.17	1.91
medial frontal gyrus, newborn, donor10223	10352-105E1	56.30	11.09	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	37.13	10.46	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	39.90	14.64	1.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	28.89	11.56	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	272.72	57.41	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	28.00	3.95	0.00
medulla oblongata - adult, donor10196	10174-103C3	33.10	12.98	1.30
medulla oblongata, adult, donor10252	10155-103A2	33.44	12.69	1.24
medulla oblongata, adult, pool1	10038-101F2	18.69	5.31	1.88
medulla oblongata, newborn, donor10223	10361-105F1	21.87	4.51	1.04
medulloblastoma cell line:D283 Med	10838-111E1	103.18	18.16	1.11
medulloblastoma cell line:ONS-76	10759-110E3	29.47	3.18	0.61
melanoma cell line:COLO 679	10514-107E1	64.54	10.35	2.73
melanoma cell line:G-361	10465-106H6	70.58	3.26	0.54
meningioma cell line:HKBMM	10691-109F7	41.43	6.15	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	101.33	23.79	14.98
merkel cell carcinoma cell line:MS-1	10844-111E7	77.77	12.44	2.59
mesenchymal precursor cell - adipose, donor1	11747-123G1	45.26	6.90	1.38
mesenchymal precursor cell - adipose, donor2	11748-123G2	48.72	7.09	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.57	9.11	1.66
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	22.48	4.78	0.84
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.03	4.62	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.07	5.55	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	30.89	4.98	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.04	2.76	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	41.25	6.37	1.72
mesenchymal precursor cell - cardiac, donor4	11755-123G9	33.76	6.21	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	37.42	3.27	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.34	5.27	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	28.78	3.60	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.29	5.24	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	26.95	3.27	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.18	3.95	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.24	4.24	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.59	2.28	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	56.22	10.07	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	30.93	2.39	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	25.12	5.78	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	25.03	4.05	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.18	3.15	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	48.00	6.32	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.38	6.85	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	28.14	7.16	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.63	6.54	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.65	5.24	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	32.01	8.47	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.45	5.42	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	21.22	5.50	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	24.10	5.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	30.57	10.67	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	25.66	5.35	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.84	7.45	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	32.27	11.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.49	6.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.15	7.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	30.50	5.58	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	13.67	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	23.38	6.50	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	23.28	7.27	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	27.19	6.40	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	14.72	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.60	4.66	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	23.09	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	20.86	6.95	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	26.68	5.93	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	36.55	8.53	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	22.80	5.07	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	15.87	10.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	10.75	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	15.97	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	6.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	25.26	6.93	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	8.74	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.04	6.48	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	20.57	6.55	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	4.01	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	10.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	7.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	15.83	6.88	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	22.27	10.39	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	11.22	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.99	8.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	22.97	3.22	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	13.08	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	7.60	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	33.38	16.39	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	58.75	22.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	38.71	13.18	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	19.64	7.94	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.03	8.11	1.95
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	6.11	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	54.16	9.28	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	76.78	9.92	3.78
mesothelioma cell line:ACC-MESO-4	10494-107B8	69.50	7.18	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	68.38	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	47.37	5.75	0.92
mesothelioma cell line:Mero-25	10850-111F4	70.36	3.40	0.91
mesothelioma cell line:Mero-41	10851-111F5	78.48	6.36	0.73
mesothelioma cell line:Mero-48a	10852-111F6	29.67	3.76	0.66
mesothelioma cell line:Mero-82	10853-111F7	77.26	4.73	1.31
mesothelioma cell line:Mero-83	10854-111F8	26.21	3.40	0.34
mesothelioma cell line:Mero-84	10855-111F9	35.39	5.31	0.76
mesothelioma cell line:Mero-95	10856-111G1	31.47	6.00	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	53.67	2.82	0.17
mesothelioma cell line:NCI-H226	10846-111E9	56.29	6.52	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	51.76	3.59	0.85
mesothelioma cell line:NCI-H28	10845-111E8	50.89	8.91	0.51
mesothelioma cell line:No36	10857-111G2	48.93	9.13	0.33
mesothelioma cell line:ONE58	10858-111G3	62.32	8.67	0.27
migratory langerhans cells, donor1	11901-125F2	23.22	2.30	0.19
migratory langerhans cells, donor2	11902-125F3	26.25	3.30	0.61
migratory langerhans cells, donor3	11903-125F4	43.61	7.00	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	73.46	4.90	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.21	5.09	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	94.68	4.15	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	39.01	8.75	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	65.23	15.89	1.29
myeloma cell line:PCM6	10474-106I6	66.81	19.96	2.57
myxofibrosarcoma cell line:MFH-ino	10600-108E6	51.74	8.12	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	37.85	5.69	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	49.92	5.24	1.23
nasal epithelial cells, donor1, tech_rep2	12226-129F3	56.41	4.85	1.10
nasal epithelial cells, donor2	12227-129F4	40.30	3.86	0.00
neuroblastoma cell line:CHP-134	10508-107D4	138.04	29.45	7.59
neuroblastoma cell line:NB-1	10539-107G8	33.11	9.17	2.43
neuroblastoma cell line:NBsusSR	10607-108F4	105.66	5.90	0.63
neuroblastoma cell line:NH-12	10555-107I6	87.03	27.39	2.61
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	51.48	19.69	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	73.49	8.87	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	26.77	6.24	1.01
neuroepithelioma cell line:SK-N-MC	10728-110A8	81.38	7.63	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	24.75	5.59	0.00
neutrophil PMN, donor1	12133-128D9	104.12	0.00	0.00
neutrophil PMN, donor2	12137-128E4	106.25	0.00	13.28
neutrophil PMN, donor3	12141-128E8	37.88	28.41	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	124.98	6.76	2.03
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	112.07	44.83	6.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	26.93	5.13	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	31.01	3.94	0.79
nucleus accumbens, adult, pool1	10037-101F1	31.50	8.34	3.09
occipital cortex - adult, donor10196	10172-103C1	51.51	12.36	4.12
occipital cortex, adult, donor10252	10163-103B1	51.26	14.49	1.88
occipital cortex, newborn, donor10223	10355-105E4	32.03	6.91	0.73
occipital lobe, adult, donor1	10076-102A4	21.52	10.50	2.10
occipital lobe, fetal, donor1	10073-102A1	20.60	4.72	1.29
occipital pole, adult, pool1	10036-101E9	21.52	2.76	0.55
olfactory region, adult	10195-103E6	29.23	10.70	1.53
optic nerve, donor1	10277-104E7	28.01	12.01	6.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	26.43	6.49	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	71.03	4.12	1.37
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	48.43	13.72	2.71
oral squamous cell carcinoma cell line:SAS	10544-107H4	50.13	4.27	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	27.34	2.35	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	240.12	41.11	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	51.74	10.39	2.76
ovary, adult, pool1	10020-101D2	40.44	13.45	1.31
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	37.58	4.22	0.37
pancreas, adult, donor1	10049-101G4	15.05	3.76	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	90.01	24.32	5.59
papillary adenocarcinoma cell line:8505C	10437-106E5	54.68	7.15	1.36
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	70.70	15.40	1.66
paracentral gyrus, adult, pool1	10035-101E8	27.46	6.22	1.19
parietal cortex, adult, donor10258	10373-105G4	19.82	11.01	0.00
parietal lobe - adult, donor10196	10171-103B9	37.62	7.52	1.88
parietal lobe, adult, donor10252	10157-103A4	39.91	9.69	1.71
parietal lobe, adult, pool1	10034-101E7	26.61	6.61	1.85
parietal lobe, fetal, donor1	10072-101I9	25.22	9.70	0.97
parietal lobe, newborn, donor10223	10356-105E5	36.64	6.73	0.37
parotid gland, adult	10199-103F1	37.62	11.72	2.47
penis, adult	10200-103F2	30.62	11.82	1.61
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	182.96	49.09	3.16
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	51.58	6.99	2.04
pineal gland - adult, donor10196	10179-103C8	32.90	7.10	3.23
pineal gland, adult, donor10252	10160-103A7	45.01	16.58	5.92
pineal gland, adult, donor10258	10377-105G8	13.17	7.52	1.88
pituitary gland - adult, donor10196	10180-103C9	50.59	15.18	1.01
pituitary gland, adult, donor10252	10162-103A9	72.97	33.36	9.38
pituitary gland, adult, donor10258	10378-105G9	33.20	14.47	3.40
placenta, adult, pool1	10021-101D3	43.86	8.82	1.83
plasma cell leukemia cell line:ARH-77	10840-111E3	85.28	17.61	3.05
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	38.13	4.05	0.93
pons, adult, pool1	10033-101E6	33.65	10.84	3.18
postcentral gyrus, adult, pool1	10032-101E5	24.15	3.57	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	96.20	14.64	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	38.56	27.54	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	35.21	11.74
prostate cancer cell line:DU145	10490-107B4	79.09	6.99	5.39
prostate cancer cell line:PC-3	10439-106E7	90.02	12.71	3.81
prostate, adult, pool1	10022-101D4	40.99	17.05	2.54
putamen, adult, donor10196	10176-103C5	52.17	10.62	4.49
putamen, adult, donor10252	10152-102I8	60.78	17.65	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	50.27	7.65	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	30.44	6.28	1.21
putamen, newborn, donor10223	10365-105F5	50.98	10.50	2.25
rectal cancer cell line:TT1TKB	10469-106I1	63.42	18.33	1.16
rectum, fetal, donor1	10067-101I4	18.08	12.52	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	73.14	16.96	2.33
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	70.42	16.15	1.24
retina, adult, pool1	10030-101E3	21.67	4.97	2.09
retinoblastoma cell line:Y79	10475-106I7	92.75	14.29	4.16
rhabdomyosarcoma cell line:KYM-1	10787-110H4	44.75	7.13	1.11
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	136.10	18.28	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	55.32	6.06	1.52
salivary acinar cells, donor1	11771-123I7	25.90	5.50	0.32
salivary acinar cells, donor2	11772-123I8	25.47	5.65	1.10
salivary acinar cells, donor3	11773-123I9	31.12	3.97	0.66
salivary gland, adult, pool1	10093-102C3	12.01	5.15	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	75.37	9.02	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	75.47	6.23	1.18
seminal vesicle, adult	10201-103F3	26.98	15.34	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	58.06	10.45	2.43
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	41.77	16.36	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	56.20	7.02	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	80.06	10.61	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	95.16	11.27	2.32
signet ring carcinoma cell line:NUGC-4	10483-107A6	62.96	13.29	2.06
skeletal muscle - soleus muscle, donor1	10282-104F3	58.17	10.64	0.71
skeletal muscle, adult, pool1	10023-101D5	49.17	15.11	1.80
skeletal muscle, fetal, donor1	10066-101I3	9.05	8.04	1.01
skin, adult, donor1	10074-102A2	20.36	6.79	0.00
skin, fetal, donor1	10065-101I2	27.14	10.73	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	70.37	12.01	6.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	32.47	12.92	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	87.89	11.76	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	203.07	27.03	3.96
small cell lung carcinoma cell line:NCI-H82	10842-111E5	110.99	24.13	2.41
small cell lung carcinoma cell line:WA-hT	10562-108A4	45.76	16.13	1.53
small intestine, adult, pool1	10024-101D6	39.89	27.47	7.17
small intestine, fetal, donor1	10064-101I1	19.66	10.07	1.97
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	23.59	3.08	0.00
smooth muscle, adult, pool1	10048-101G3	20.42	13.70	1.03
somatostatinoma cell line:QGP-1	10781-110G7	34.57	2.95	0.80
spinal cord - adult, donor10196	10181-103D1	33.95	8.95	2.29
spinal cord, adult, donor10252	10159-103A6	52.83	16.17	5.13
spinal cord, adult, donor10258	10369-105F9	28.36	21.45	0.69
spinal cord, fetal, donor1	10056-101H2	12.20	7.93	1.83
spinal cord, newborn, donor10223	10359-105E8	39.95	14.24	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	40.48	3.58	1.05
spleen, adult, pool1	10025-101D7	35.68	14.98	1.98
spleen, fetal, pool1	10044-101F8	21.85	4.37	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	65.83	14.28	1.97
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	71.39	12.15	3.23
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	29.00	7.69	2.10
squamous cell carcinoma cell line:T3M-5	10616-108G4	72.71	4.69	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	88.25	19.14	6.98
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.45	5.93	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	45.27	2.12	0.42
stomach, fetal, donor1	10062-101H8	43.79	10.68	0.00
submaxillary gland, adult	10202-103F4	32.47	9.11	1.14
substantia nigra - adult, donor10196	10178-103C7	217.10	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	44.66	10.18	4.15
substantia nigra, adult, donor10258	10371-105G2	34.66	5.69	0.00
substantia nigra, newborn, donor10223	10358-105E7	19.78	3.53	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	72.22	11.92	1.83
temporal lobe, adult, pool1	10031-101E4	21.19	3.98	0.68
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	22.08	4.27	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	32.09	7.03	0.88
tenocyte, donor1	11763-123H8	24.09	1.75	0.35
tenocyte, donor2	11765-123I1	21.36	2.29	0.00
tenocyte, donor3	11768-123I4	17.79	3.34	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	59.15	5.44	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	39.00	13.87	2.16
teratocarcinoma cell line:PA-1	10807-111A6	44.01	13.95	3.72
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	75.53	11.43	2.54
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	149.76	51.81	7.56
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	87.36	49.19	6.54
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	85.66	26.71	3.91
testis, adult, pool1	10026-101D8	81.07	9.77	1.83
testis, adult, pool2	10096-102C6	50.97	4.51	1.35
thalamus - adult, donor10196	10168-103B6	34.22	7.73	1.10
thalamus, adult, donor10252	10154-103A1	45.32	14.38	3.75
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	12.32	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.86	5.27	1.48
thalamus, newborn, donor10223	10366-105F6	24.74	4.03	0.00
throat, adult	10209-103G2	26.71	14.23	2.25
throat, fetal, donor1	10061-101H7	21.33	14.32	3.66
thymic carcinoma cell line:Ty-82	10803-111A2	80.88	13.12	1.59
thymus, adult, pool1	10027-101D9	35.99	13.32	2.88
thymus, fetal, pool1	10043-101F7	38.34	14.44	3.01
thyroid carcinoma cell line:KHM-5M	10776-110G2	52.52	9.31	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	41.07	6.01	1.26
thyroid, adult, pool1	10028-101E1	44.88	22.21	3.83
thyroid, fetal, donor1	10060-101H6	23.47	9.23	3.16
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	0.00	0.00
tongue, adult	10203-103F5	31.17	16.51	2.09
tongue, fetal, donor1	10059-101H5	20.10	10.25	0.79
tonsil, adult, pool1	10047-101G2	30.35	5.71	1.60
trachea, adult, pool1	10029-101E2	33.21	11.21	1.80
trachea, fetal, donor1	10058-101H4	21.16	7.31	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	33.66	3.90	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	59.47	8.81	1.93
transitional-cell carcinoma cell line:JMSU1	10492-107B6	89.47	17.08	2.51
tridermal teratoma cell line:HGRT	10694-109G1	57.08	19.03	3.81
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	33.44	10.16	2.37
umbilical cord, fetal, donor1	10057-101H3	10.43	12.52	0.00
uterus, adult, pool1	10100-102D1	30.71	9.04	0.17
uterus, fetal, donor1	10055-101H1	23.04	9.21	0.51
vagina, adult	10204-103F6	52.99	3.88	0.65
vein, adult	10191-103E2	26.08	12.28	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	34.18	7.74	1.07